Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Clinical Feasibility of the ARCHITECT Applicator in Cervical Cancer Brachytherapy

NCT: NCT07435987 · RECRUITING

NCT IDNCT07435987
StatusRECRUITING
Start Date2026-07-22
Completion2027-12
SponsorErasmus Medical Center (OTHER)
First posted
Last updated

Brief Summary

This prospective, non-randomised, single centre, phase I trial assesses the clinical feasibility of the use of the patient-tailored ARCHITECT applicator in locally advanced cervical cancer brachytherapy.

Frequently Asked Questions

What is Clinical Feasibility of the ARCHITECT Applicator in Cervical Cancer Brachytherapy?

Clinical Feasibility of the ARCHITECT Applicator in Cervical Cancer Brachytherapy is a clinical trial registered under NCT07435987. Current status: RECRUITING.

What is the status of NCT07435987?

The current status of NCT07435987 (Clinical Feasibility of the ARCHITECT Applicator in Cervical Cancer Brachytherapy) is: RECRUITING.

When did Clinical Feasibility of the ARCHITECT Applicator in Cervical Cancer Brachytherapy start?

Clinical Feasibility of the ARCHITECT Applicator in Cervical Cancer Brachytherapy started on 2026-07-22.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑